1. Plasma Branched-Chain and Aromatic Amino Acids in Relation to Hypertension
- Author
-
Yasutaka Ishimaru, Ryosuke Hase, Shinya Kikuchi, Rie Watanabe, Hiroshi Yamamoto, Junki Shimokawa, Tsuyoshi Tanabe, M. H. Mahbub, Hiroyuki Saito, Natsu Yamaguchi, and Hidekazu Takahashi
- Subjects
Adult ,Male ,0301 basic medicine ,hypertension ,aromatic ,Physiology ,lcsh:TX341-641 ,030204 cardiovascular system & hematology ,Logistic regression ,Risk Assessment ,Article ,Amino Acids, Aromatic ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Japan ,plasma amino acids ,Aromatic amino acids ,Humans ,Medicine ,chemistry.chemical_classification ,Nutrition and Dietetics ,business.industry ,Incidence ,Confounding ,Middle Aged ,Current analysis ,Large cohort ,Amino acid ,branched-chain ,Cross-Sectional Studies ,030104 developmental biology ,chemistry ,Quartile ,Heart Disease Risk Factors ,Case-Control Studies ,Female ,business ,lcsh:Nutrition. Foods and food supply ,Amino Acids, Branched-Chain ,Biomarkers ,Food Science - Abstract
Findings of the available studies regarding the roles of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) in hypertension are inconsistent, conflicting and inconclusive. The purpose of this study was to explore and clarify the existence of any relationships of individual BCAAs and AAAs with hypertension with adjustments for potential relevant confounders. A total of 2805 healthy controls and 2736 hypertensive patients were included in the current analysis. The associations between individual amino acids and hypertension were explored by logistic regression analyses adjusted for potential confounding variables. Among the investigated amino acids, only the BCAAs showed consistently significant positive associations with hypertension in the adjusted models (p-trend <, 0.05 to 0.001). However, compared with the corresponding lowest quartile of individual BCAAs, the positive association with hypertension remained significant only in the highest quartile (p <, 0.01 to 0.001). We confirmed in a relatively large cohort of subjects that BCAAs, not AAAs, demonstrated consistent positive associations with hypertension. The results display the promising potential for the use of BCAAs as relevant and accessible biomarkers, and provide perspectives on interventions directed towards the reduction in plasma BCAA levels in the prevention and management of hypertension.
- Published
- 2020
- Full Text
- View/download PDF